GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: CDX-011 | CR011-vcMMAE
Compound class:
Antibody
Comment: Glembatumumab vedotin is a fully human anti-gpNMB (transmembrane glycoprotein NMB; gene symbol GPNMB) monoclonal antibody-drug conjugate (ADC) carrying the antineoplastic toxin monomethyl auristatin E (MMAE; PubChem CID 11542188). Development and preclinical evaluation of this ADC is reported in [4].
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. |
Classification ![]() |
|
| Compound class | Antibody |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 10123 | glembatumumab vedotin |
Synonyms ![]() |
| CDX-011 | CR011-vcMMAE |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 565 |
| Other databases | |
| GtoPdb PubChem SID | 310264707 |
| Search PubMed clinical trials | glembatumumab vedotin |
| Search PubMed titles | glembatumumab vedotin |
| Search PubMed titles/abstracts | glembatumumab vedotin |
| Wikipedia | Glembatumumab vedotin |